FDA Staff Call For Broader Cancer Trial Eligibility Criteria

Apr 21, 2017, 10:29 by Michael Croft

BioCentury | Richard Pazdur, director of FDA's Oncology Center of Excellence, called for rational approaches to broadening clinical trial eligibility criteria, including enrolling patients aged under 18 in adult trials, to improve cancer studies by capturing the heterogeneity of patient populations that would use therapies after they are approved.

April 21, 2017 | Richard Pazdur, director of FDA's Oncology Center of Excellence, called for rational approaches to broadening clinical trial eligibility criteria, including enrolling patients aged under 18 in adult trials, to improve cancer studies by capturing the heterogeneity of patient populations that would use therapies after they are approved. BioCentury